Adherence to, and effectiveness of, subcutaneous interferon beta-1a administered by RebiSmart (R) in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study

Antonios Bayas, Jean Christophe Ouallet, Boris Kallmann, Raymond Hupperts, Ulrich Fulda, Kurt Marhardt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1239-1250
JournalExpert Opinion on Drug Delivery
Volume12
Issue number8
DOIs
Publication statusPublished - Aug 2015

Keywords

  • adherence
  • autoinjector
  • interferon beta
  • multiple sclerosis

Cite this